{
    "2020-08-17": [
        [
            {
                "time": "",
                "original_text": "华东医药3.7亿元入股荃信生物 目标公司拥有8个在研药品",
                "features": {
                    "keywords": [
                        "华东医药",
                        "荃信生物",
                        "股权融资",
                        "在研药品"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药携手荃信生物 深度布局自免单抗管线",
                "features": {
                    "keywords": [
                        "华东医药",
                        "荃信生物",
                        "战略合作",
                        "自免单抗"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "免疫治疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药(000963.SZ)：中美华东拟3.7亿元对荃信生物进行股权投资 双方已签订产品合作开发协议",
                "features": {
                    "keywords": [
                        "华东医药",
                        "中美华东",
                        "荃信生物",
                        "股权投资",
                        "产品开发协议"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药：子公司中美华东与荃信生物达成股权投资和产品合作开发协议",
                "features": {
                    "keywords": [
                        "华东医药",
                        "中美华东",
                        "荃信生物",
                        "股权投资",
                        "产品开发"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药：拟对荃信生物进行股权投资将成为其第二大股东",
                "features": {
                    "keywords": [
                        "华东医药",
                        "荃信生物",
                        "股权投资",
                        "第二大股东"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "苑东生物多项财务数据异常，“穿越时空”与供应商合作 欺诈造假",
                "features": {
                    "keywords": [
                        "苑东生物",
                        "财务数据异常",
                        "欺诈造假",
                        "供应商合作"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}